Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)
Original languageEnglish
Pages (from-to)763-776
Number of pages14
JournalJournal of Pediatric Gastroenterology and Nutrition
Issue number6
Publication statusPublished - 2020

Research programs

  • EMC MM-04-54-07

Cite this